Published in J Vasc Surg on January 01, 2005
Percutaneous revascularization for ischemic nephropathy: the past, present, and future. Kidney Int (2012) 1.12
Drug-eluting stents in renal artery stenosis. Eur Radiol (2007) 0.90
Update on intervention versus medical therapy for atherosclerotic renal artery stenosis. J Vasc Surg (2015) 0.80
Experience of stenting for atherosclerotic renal artery stenosis in a cardiac catheterization laboratory: technical considerations and complications. Can J Cardiol (2009) 0.78
Restenosis after renal artery angioplasty and stenting: incidence and risk factors. J Vasc Surg (2009) 0.78
Clinical effectiveness of secondary interventions for restenosis after renal artery stenting. J Vasc Surg (2013) 0.75
Plasma Renin Activity Predicts the Improvement in Resistant Hypertension after Percutaneous Transluminal Renal Artery Angioplasty. Intern Med (2016) 0.75
Coronary-like revascularization for atherosclerotic renal artery stenosis--results in 181 consecutive patients. Clin Res Cardiol (2006) 0.75
Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg (2010) 3.45
Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg (2002) 3.35
Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry. J Vasc Surg (2008) 3.06
Derivation and validation of a practical risk score for prediction of mortality after open repair of ruptured abdominal aortic aneurysms in a US regional cohort and comparison to existing scoring systems. J Vasc Surg (2012) 2.78
The effect of postoperative myocardial ischemia on long-term survival after vascular surgery. J Vasc Surg (2013) 2.72
Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg (2003) 2.71
National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg (2009) 2.55
Endovascular vs open repair for ruptured abdominal aortic aneurysm. J Vasc Surg (2012) 2.23
Factors associated with stroke or death after carotid endarterectomy in Northern New England. J Vasc Surg (2008) 2.22
Regional variation in carotid artery stenting and endarterectomy in the Medicare population. Circ Cardiovasc Qual Outcomes (2009) 2.21
Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival. J Vasc Surg (2013) 2.16
Decrease in total aneurysm-related deaths in the era of endovascular aneurysm repair. J Vasc Surg (2009) 2.16
The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) (2002) 2.10
Thoracic endovascular aneurysm repair, race, and volume in thoracic aneurysm repair. J Vasc Surg (2012) 2.07
Withdrawal of article by the FDA after objection from Medtronic. J Vasc Surg (2004) 2.04
Intraoperative use of dextran is associated with cardiac complications after carotid endarterectomy. J Vasc Surg (2013) 2.02
Thirty-day mortality and late survival with reinterventions and readmissions after open and endovascular aortic aneurysm repair in Medicare beneficiaries. J Vasc Surg (2010) 2.02
Survival after open versus endovascular thoracic aortic aneurysm repair in an observational study of the Medicare population. Circulation (2011) 2.00
Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet (2003) 1.98
Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg (2004) 1.96
Regulation of vascular smooth muscle cell differentiation. J Vasc Surg (2007) 1.92
In vivo analysis of mechanical wall stress and abdominal aortic aneurysm rupture risk. J Vasc Surg (2002) 1.92
Factors associated with death 1 year after lower extremity bypass in Northern New England. J Vasc Surg (2009) 1.86
Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg (2009) 1.81
Infliximab in the treatment of refractory posterior uveitis. Ophthalmology (2003) 1.75
Stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria. J Vasc Surg (2010) 1.73
Endovascular abdominal aortic aneurysm repair: long-term outcome measures in patients at high-risk for open surgery. J Vasc Surg (2006) 1.68
Population-based outcomes following endovascular and open repair of ruptured abdominal aortic aneurysms. J Endovasc Ther (2009) 1.68
Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg (2012) 1.65
Epidural anesthesia and analgesia: effects on recovery from cardiac surgery. J Cardiothorac Vasc Anesth (2002) 1.64
Impact of screening versus symptomatic measurement of deep vein thrombosis in a national quality improvement registry. J Vasc Surg (2012) 1.63
A regional quality improvement effort to increase beta blocker administration before vascular surgery. J Vasc Surg (2011) 1.61
Accuracy of administrative data versus clinical data to evaluate carotid endarterectomy and carotid stenting. J Vasc Surg (2013) 1.59
Mesenteric revascularization: management and outcomes in the United States, 1988-2006. J Vasc Surg (2009) 1.58
The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol (2003) 1.57
Carotid endarterectomy in asymptomatic patients with limited life expectancy. Stroke (2012) 1.54
Outcomes and practice patterns in patients undergoing lower extremity bypass. J Vasc Surg (2012) 1.53
Impact of practice patterns in shunt use during carotid endarterectomy with contralateral carotid occlusion. J Vasc Surg (2011) 1.53
Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum (2003) 1.51
Management and classification of type II congenital portosystemic shunts. J Pediatr Surg (2011) 1.50
Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg (2008) 1.50
Risk prediction for perioperative mortality of endovascular vs open repair of abdominal aortic aneurysms using the Medicare population. J Vasc Surg (2009) 1.46
Carotid artery stenting and patient outcomes: the CABANA surveillance study. Catheter Cardiovasc Interv (2014) 1.45
In-vivo imaging of changes in abdominal aortic aneurysm thrombus volume during the cardiac cycle. J Endovasc Ther (2009) 1.45
The impact of endovascular procedures on fellowship training in lower extremity revascularization. J Vasc Surg (2012) 1.44
Predicting 1-year mortality after elective abdominal aortic aneurysm repair. J Vasc Surg (2009) 1.43
Impact of dynamic computed tomographic angiography on endograft sizing for endovascular aneurysm repair. J Endovasc Ther (2009) 1.39
Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling. J Biol Chem (2007) 1.35
The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg (2010) 1.34
Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: Implications for rupture risk. J Vasc Surg (2004) 1.34
Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair. J Vasc Surg (2002) 1.29
Isolated dissection of the abdominal aorta: clinical presentation and therapeutic options. J Vasc Surg (2002) 1.28
Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 1.26
Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther (2004) 1.23
Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour. Immunology (2004) 1.22
National trends and regional variation of open and endovascular repair of thoracic and thoracoabdominal aneurysms in contemporary practice. J Vasc Surg (2011) 1.22
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition. Circ Res (2008) 1.17
Gender differences in abdominal aortic aneurysm presentation, repair, and mortality in the Vascular Study Group of New England. J Vasc Surg (2013) 1.17
Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg (2011) 1.16
Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum (2006) 1.16
Risk of late-onset adhesions and incisional hernia repairs after surgery. J Am Coll Surg (2013) 1.16
Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia. J Vasc Surg (2007) 1.15
Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg (2011) 1.13
The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway. Am J Physiol Heart Circ Physiol (2006) 1.12
Body mass index: surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007. Ann Vasc Surg (2009) 1.12
Vascular injury during anterior exposure of the spine. J Vasc Surg (2008) 1.12
Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Ann Vasc Surg (2009) 1.09
Preoperative pulse pressure and major perioperative adverse cardiovascular outcomes after lower extremity vascular bypass surgery. Anesth Analg (2011) 1.09
Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia. J Vasc Surg (2010) 1.08
Mesenteric stenting for chronic mesenteric ischemia. J Vasc Surg (2005) 1.08